APA

Lacas B., Bouché O., Etienne P., Gasmi M., Texereau P., Gargot D., Lombard-Bohas C., Azzedine A., Denis B., Geoffroy P., Auby D., Michel P., Pignon J., Lepage C., Ducreux M. & Borget I. (20191004). Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial. : Expert review of pharmacoeconomics & outcomes research.

Chicago

Lacas Benjamin, Bouché Olivier, Etienne Pierre-Luc, Gasmi Mohamed, Texereau Patrick, Gargot Dany, Lombard-Bohas Catherine, Azzedine Ahmed, Denis Bernard, Geoffroy Patrick, Auby Dominique, Michel Pierre, Pignon Jean-Pierre, Lepage Côme, Ducreux Michel and Borget Isabelle. 20191004. Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial. : Expert review of pharmacoeconomics & outcomes research.

Harvard

Lacas B., Bouché O., Etienne P., Gasmi M., Texereau P., Gargot D., Lombard-Bohas C., Azzedine A., Denis B., Geoffroy P., Auby D., Michel P., Pignon J., Lepage C., Ducreux M. and Borget I. (20191004). Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial. : Expert review of pharmacoeconomics & outcomes research.

MLA

Lacas Benjamin, Bouché Olivier, Etienne Pierre-Luc, Gasmi Mohamed, Texereau Patrick, Gargot Dany, Lombard-Bohas Catherine, Azzedine Ahmed, Denis Bernard, Geoffroy Patrick, Auby Dominique, Michel Pierre, Pignon Jean-Pierre, Lepage Côme, Ducreux Michel and Borget Isabelle. Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial. : Expert review of pharmacoeconomics & outcomes research. 20191004.